Difference between revisions of "Sancak Y, et al. Mol. Cell (2007) cited as Ref 357 in DOI: 10.1038/s41392-020-0110-5 (Q9620)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 25, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase (English) | ||
| Property / title: PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:00, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Sancak Y, et al. Mol. Cell (2007) cited as Ref 357 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Sancak Y
0 references
2007
0 references
Mol. Cell
0 references
25
0 references
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase (English)
0 references
